C57BL/6JCya-Wrnem1/Cya
Common Name:
Wrn-KO
Product ID:
S-KO-05799
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Wrn-KO
Strain ID
KOCMP-22427-Wrn-B6J-VA
Gene Name
Product ID
S-KO-05799
Gene Alias
-
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
8
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Wrnem1/Cya mice (Catalog S-KO-05799) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000033990
NCBI RefSeq
NM_011721
Target Region
Exon 9~10
Size of Effective Region
~3.0 kb
Detailed Document
Overview of Gene Research
WRN, the gene encoding the Werner Syndrome RecQ helicase, is crucial for genome stability, involved in processes like DNA replication, base excision repair, recombination, DNA damage response, and transcription [4,6,8]. It is also an exonuclease and ATPase, playing a key role particularly during DNA replication and telomere metabolism [6]. Mutations in WRN cause Werner syndrome, a segmental progeroid syndrome with features of premature aging [4,6].
Cancer cells with microsatellite instability (MSI) are dependent on WRN helicase for survival [2,3,5,7,9]. In MSI-H cells, WRN inhibition traps the helicase on chromatin, leading to its degradation via the PIAS4-RNF4-p97/VCP axis [2]. WRN helicase can unfold cruciform DNA structures formed by TA nucleotide repeats, and its downregulation in MSI cells with expanded TA repeats causes DNA breaks and cell lethality [5]. Targeting WRN with small-molecule inhibitors, RNA interference, or EGS/RNase P targeting systems could be beneficial for selective cancer therapy as helicase depletion reduces cell viability due to mitotic catastrophe triggered by replication stress [8]. However, discovering specific non-covalent WRN helicase inhibitors has been challenging due to a high propensity for artefacts via protein interference [1].
In summary, WRN is essential for genome stability, and its role in DNA-related processes is well-established. The discovery of its synthetic lethality in MSI cancers offers a promising target for cancer therapy. The study of WRN in MSI-related cancers through various research models, though facing challenges in inhibitor discovery, may lead to new therapeutic modalities.
References:
1. Heuser, Alisa, Abdul Rahman, Wassim, Bechter, Elisabeth, Möbitz, Henrik, Hamon, Jacques. 2024. Challenges for the Discovery of Non-Covalent WRN Helicase Inhibitors. In ChemMedChem, 19, e202300613. doi:10.1002/cmdc.202300613. https://pubmed.ncbi.nlm.nih.gov/38334957/
2. Rodríguez Pérez, Fernando, Natwick, Dean, Schiff, Lauren, Bashore, Charlene, Basham, Stephen. 2024. WRN inhibition leads to its chromatin-associated degradation via the PIAS4-RNF4-p97/VCP axis. In Nature communications, 15, 6059. doi:10.1038/s41467-024-50178-3. https://pubmed.ncbi.nlm.nih.gov/39025847/
3. Wainberg, Zev A. . WRN Helicase: Is There More to MSI-H than Immunotherapy? In Cancer discovery, 14, 1369-1371. doi:10.1158/2159-8290.CD-24-0771. https://pubmed.ncbi.nlm.nih.gov/39091203/
4. Hisama, Fuki M, Bohr, Vilhelm A, Oshima, Junko. 2006. WRN's tenth anniversary. In Science of aging knowledge environment : SAGE KE, 2006, pe18. doi:. https://pubmed.ncbi.nlm.nih.gov/16807482/
5. Mengoli, Valentina, Ceppi, Ilaria, Sanchez, Aurore, Pettazzoni, Piergiorgio, Cejka, Petr. 2022. WRN helicase and mismatch repair complexes independently and synergistically disrupt cruciform DNA structures. In The EMBO journal, 42, e111998. doi:10.15252/embj.2022111998. https://pubmed.ncbi.nlm.nih.gov/36541070/
6. Katsuya, Tomohiro, Morishita, Ryuichi. . [WRN gene]. In Nihon rinsho. Japanese journal of clinical medicine, 67, 1277-82. doi:. https://pubmed.ncbi.nlm.nih.gov/19591272/
7. van Wietmarschen, Niek, Nathan, William J, Nussenzweig, André. 2021. The WRN helicase: resolving a new target in microsatellite unstable cancers. In Current opinion in genetics & development, 71, 34-38. doi:10.1016/j.gde.2021.06.014. https://pubmed.ncbi.nlm.nih.gov/34284257/
8. Orlovetskie, Natalie, Serruya, Raphael, Abboud-Jarrous, Ghada, Jarrous, Nayef. 2016. Targeted inhibition of WRN helicase, replication stress and cancer. In Biochimica et biophysica acta. Reviews on cancer, 1867, 42-48. doi:10.1016/j.bbcan.2016.11.004. https://pubmed.ncbi.nlm.nih.gov/27902925/
9. Morales-Juarez, David A, Jackson, Stephen P. 2022. Clinical prospects of WRN inhibition as a treatment for MSI tumours. In NPJ precision oncology, 6, 85. doi:10.1038/s41698-022-00319-y. https://pubmed.ncbi.nlm.nih.gov/36379964/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen